News

Newsletter

November 19, 2020

ANVISA decides that a patent application related to pharmaceutical use of cannabinoids is not to be deemed as against public health

On November 17th, 2020, ANVISA’s Board of Directors (BoD) unanimously granted an administrative appeal for reassessment of prior consent of a patent application for an invention covering several cannabinoids (including THC) for pain treatment. The BoD considered that mere use of cannabinoids within the invention is not to be deemed as a threat to public health.
 
ANVISA’s BoD unanimously granted the administrative appeal and ordered COOPI to reassess the case. Rapporteur Director Antonio Barra Torres understood that denying prior consent only because an invention comprises the use of cannabinoids disregards relevant legal and sanitary aspects that should be taken into account. Director Alessandra Bastos Soares also noted that ANVISA’s Intellectual Property Coordination Office (COOPI) must take note of what has been decided by BoD on the subject, which is of great importance.
 
For further information, access here our full newsletter.
Back

Last related news

November 25, 2022

FTX Investor Sues Gisele Bündchen And Other Celebrities For Deceptive Practices

The financial collapse of FTX regarded as one of the largest cryptocurrency exchanges in the world brought with it not only financial FTX Investor Sues Gisele Bündchen And Other Celebrities For Deceptive Practices

Ler notícia

November 24, 2022

New Decision From The Brazilian Supreme Court In Favor Of Patent Term Adjustment (PTA) Cases

A new decision from the Brazilian Supreme Court on November 16th brought some hope to patent owners seeking the term adjustment for patents New Decision From The Brazilian Supreme Court In Favor Of Patent Term Adjustment (PTA) Cases

Ler notícia

November 22, 2022

New decision from the Brazilian Supreme Court in favor of Patent Term Adjustment (PTA) cases

A new decision from the Brazilian Supreme Court on November 16th brought some hope to patent owners seeking the term adjustment for patents New decision from the Brazilian Supreme Court in favor of Patent Term Adjustment (PTA) cases

Ler notícia